Health and Fitness Health and Fitness
Mon, March 11, 2013
[ Mon, Mar 11th 2013 ] - Market Wire
Abattis Terminates $600,000 Private Placement
[ Mon, Mar 11th 2013 ] - Market Wire
Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
[ Mon, Mar 11th 2013 ] - Market Wire
Emerging Growth Equities, Ltd. Initiates Coverage .. . (SRPT) With a BUY Rating and $38.00 Price Targe
[ Mon, Mar 11th 2013 ] - Market Wire
Hill-Rom Elects William H. Kucheman to its Board of Directors
[ Mon, Mar 11th 2013 ] - Market Wire
Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years
[ Mon, Mar 11th 2013 ] - Market Wire
SurgiCount Medical Announces The Appointment Of M .. hael Roux As Vice President of Product Management
[ Mon, Mar 11th 2013 ] - Market Wire
VistaGen Therapeutics to Present CardioSafe 3D(TM .. ts at Society of Toxicology's 52nd Annual Meeting
[ Mon, Mar 11th 2013 ] - Market Wire
New Data Reinforce Strong Long-Term Clinical Perf .. Abbott's Absorba" Bioresorbable Vascular Scaffold
[ Mon, Mar 11th 2013 ] - Market Wire
GeoVax Labs Reports 2012 Financial Results and Progress
[ Mon, Mar 11th 2013 ] - Market Wire
Sirona Biochem Signs Material Transfer Agreement with VitamFero
[ Mon, Mar 11th 2013 ] - Market Wire
First Center in Hong Kong Treats Patients with CyberKnife and TomoTherapy Systems
[ Mon, Mar 11th 2013 ] - Market Wire
Outlook for Diagnostic Substances Industry
[ Mon, Mar 11th 2013 ] - Market Wire
Insmed to Host Fourth Quarter and Full Year 2012 .. Results Conference Call on Monday, March 18, 2013
[ Mon, Mar 11th 2013 ] - Market Wire
Suit Against Micro Imaging Technology Dismissed by Texas Court
[ Mon, Mar 11th 2013 ] - Market Wire
Simcere Pharmaceutical Group Announces Receipt of quot;;Going Privatequot;; Proposal
[ Mon, Mar 11th 2013 ] - Market Wire
Horizon Pharma to Present at the 25th Annual ROTH Conference
[ Mon, Mar 11th 2013 ] - Market Wire
Implant Sciences to Present at Global Security Asia 2013 Conference
[ Mon, Mar 11th 2013 ] - Market Wire
Sunshine Heart Reports Fourth Quarter and Full Year 2012 Results
Sun, March 10, 2013
[ Sun, Mar 10th 2013 ] - Market Wire
The Medicines Company's Intravenous Cangrelor Dem .. n in Ischemic Events Compared to Oral Clopidogrel
[ Sun, Mar 10th 2013 ] - Market Wire
The Boston Scientific PROMUS Elementa" Platinum C .. tes Continued Low Event Rates Through Three Years
[ Sun, Mar 10th 2013 ] - Market Wire
Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes
Sat, March 9, 2013
[ Sat, Mar 09th 2013 ] - Market Wire
Presentation of Preliminary Results From Boston Scientific PREVAIL Clinical Trial Now Available
[ Sat, Mar 09th 2013 ] - Market Wire
The Boston Scientific Watchman Device Continues T .. al Outcomes For Patients With Atrial Fibrillation
[ Sat, Mar 09th 2013 ] - Market Wire
Results from HPS2-THRIVE Study of TREDAPTIVEa" (e .. prant) Presented at American College of Cardiolog
Fri, March 8, 2013
[ Fri, Mar 08th 2013 ] - Market Wire
Abattis Participates In Project On A Whole Plant .. ria And Other Diseases And Reducing Drug Resistan
[ Fri, Mar 08th 2013 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against Impax Laboratories, Inc
[ Fri, Mar 08th 2013 ] - Market Wire
Toronto Stock Exchange Defers Consideration of Shareholder Rights Plan
[ Fri, Mar 08th 2013 ] - Market Wire
NxStage Educational Reception at Annual Dialysis .. s Celebrity and Former NxStage User Stephen Furst
[ Fri, Mar 08th 2013 ] - Market Wire
BrainStorm Cell Therapeutics Presents at the 11th .. Conference on Alzheimer's and Parkinson's Disease
[ Fri, Mar 08th 2013 ] - Market Wire
The Medicines Company to Host Cangrelor Webcast on Sunday, March 10, 2013

The Medicines Company to Host Cangrelor Webcast on Sunday, March 10, 2013


Published on 2013-03-08 07:30:48 - Market Wire
  Print publication without navigation


March 08, 2013 10:22 ET

The Medicines Company to Host Cangrelor Webcast on Sunday, March 10, 2013

Conference Call to Be Held at 11:00 a.m. Pacific Time

PARSIPPANY, NJ--(Marketwire - Mar 8, 2013) - The Medicines Company (NASDAQ: [ MDCO ]) has scheduled a conference call and webcast following release of the Phase 3 cangrelor CHAMPION PHOENIX trial results on Sunday, March 10, 2013 at 11:00 a.m. Pacific Time, 2:00 p.m. Eastern Time. MDCO management and experts are scheduled to discuss cangrelor trial results and outlook.

The conference call will be available via phone and webcast. The dial in information is listed below:

Domestic Dial In: 866 700.6067 
International Dial In: 617 213.8834 
Passcode for both dial in numbers: 54431050 

Replay is available from 4:00 p.m. Eastern Time following the conference call through March 17, 2013. To hear a replay of the call, dial 888 286.8010 (domestic) and 617 801.6888 (international). Passcode for both dial in numbers is 17733784.

This call is being webcast and can be accessed at The Medicines Company website at [ www.themedicinescompany.com ].

About The Medicines Company
The Medicines Company (NASDAQ: [ MDCO ]) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is [ www.themedicinescompany.com ].


Contributing Sources